Butterfly Medical Secures $21 Million in Upsized Series C Funding to Advance Minimally Invasive BPH Treatment

Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced ...
GlobalData on MSN

Butterfly Medical raises $21m in funds for BPH device development

The company has completed its pivotal clinical trial for the Butterfly prostatic retraction device.
MedPage Today on MSN

Temporary prostatic urethra expander for BPH/LUTS shows durable results

Study showed immediate improvement in symptoms after intentional retrieval of device at 6 ...
Business Wire

MarinHealth Medical Center Surgeons Perform New AI-Powered Aquablation Procedure for the Treatment of Benign Prostatic Hyperplasia

GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
Nature

Measurement of benign prostatic hyperplasia treatment effects on male sexual function

Benign prostatic hyperplasia (BPH) is the leading cause of lower urinary tract symptoms among the aging male population. Epidemiological, pathophysiological and clinical studies indicate that many of ...
Baylor College of Medicine

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign Prostatic Hyperplasia (BPH), also known as an enlarged prostate, is a common condition in older men. It occurs when the prostate gland grows in size, causing compression of the urethra.
MassDevice

Butterfly Medical raises $21M for BPH device

Butterfly Medical announced today that it completed its Series C funding round, bringing in $21 million to support its BPH ...